Recruiting Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas NCT06176027 Conditions Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more Locations Navy General Hospital — Beijing, Beijing Municipality, China View Trial Details
